People
BioArctic AB announced that the company has recruited the internationally renowned scientist Dr. Per-Ola Freskgård to strengthen BioArctic’s development of its technology platform to facilitate passage of antibodies and other biologics across the blood-brain barrier.
Biopharma companies from across the globe strengthen their leadership teams with key executive appointments.
Pharma and biotech companies have been developing cutting-edge treatments and medications for a myriad of diseases but, for some patients, getting those medications has become a herculean task.
A paper published by Tillman Gerngross, chief executive officer of Adimab LLC, alleged that an MIT professor’s work was nearly identical to work published several years before his.
Joins MD Anderson from University Health Network/Princess Margaret Cancer Centre
Appointment of Mr Vince Ippolito, a US-based dermatology industry leader with over 30 years of pharmaceuticals experience as President of Botanix
Tom Richardson, president of ILSE, told BioSpace that it’s a shame how New Jersey is often overlooked as a life sciences hub, particularly when a quick glance at the state’s ecosystem reveals the extensive presence of pharma, biotech and other assets of the industry.
Former commissioner of the U.S. Food and Drug Administration, Scott Gottlieb, although not running for office (that we are aware of), recently published commentary urging the United States to avoid making it more difficult for poor people to gain access to cutting-edge medications.
Anima Biotech is merging mRNA therapeutics with its own AI and bioinformatics capability. Yochi Slonim, co-founder and chief executive officer of Anima Biotech, took time to speak with BioSpace about the company and mRNA therapeutics.
The NIH program aims to recruit up to 15 investigators from diverse backgrounds each year and to provide the investigators with mentoring and other professional development activities.
PRESS RELEASES